Eli Lilly vows to extend public&s grant access globally

Eli Lilly, the first drug company to make data on its US educational grants accessible to the public, vowed to extend the policy globally by 2008. Meanwhile, it published its second full quarter of grants online.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions